Last edition
News about "AI drug discovery "
Insilico Medicine and Takeda Collaborate on AI Drug Discovery
Takeda and Insilico Medicine are collaborating to advance Artificial Intelligence (AI)-powered drug discovery, leveraging the Pharma.AI platform to accelerate the development of therapeutics.
AI Drug Discovery | 02/07/2026 | By News Bureau
LG AI Research Partners with D&D Pharmatech for Oral Peptide Drug Discovery
LG AI Research and D&D Pharmatech have partnered to accelerate next-generation oral peptide drug discovery using advanced AI technologies. The collaboration aims to enhance drug development efficiency and strengthen LG’s leadership in the rapidly growing AI-driven biopharmaceutical market.
AI Drug Discovery | 18/06/2026 | By News Bureau | 101
Sygnature Discovery Partners with DaltonTx to Advance AI-Driven Drug Discovery
Sygnature Discovery has partnered with DaltonTx to enhance Artificial Intelligence (AI)-enabled drug discovery capabilities, accelerating medicinal chemistry decision-making while maintaining robust data security standards to support faster and more efficient therapeutic research and development.
AI Drug Discovery | 05/06/2026 | By News Bureau | 132
Incyte and Genesis Molecular AI have expanded their strategic collaboration to deploy advanced molecular AI technologies and proprietary research data, aiming to accelerate drug discovery and develop next-generation therapies through AI-powered molecular design.
AI Drug Discovery | 22/05/2026 | By News Bureau | 251
Kazia Expands Oncology Platform with First-in-Class SETDB1 Inhibitor
Kazia Therapeutics expands its oncology platform with a first-in-class SETDB1 inhibitor, leveraging an AI-driven epigenetic drug discovery engine for faster and scalable candidate development.
AI Drug Discovery | 15/04/2026 | By News Bureau | 162
Eli Lilly Eyes USD 2 Billion AI Drug Discovery Deal with Insilico Medicine
Eli Lilly is set to enter into a deal worth over USD 2 billion with Hong Kong-based Insilico Medicine to accelerate drug discovery using artificial intelligence, signaling a major push toward AI-driven pharmaceutical innovation.
AI Drug Discovery | 30/03/2026 | By Darshana | 193
Absci Partners with AMD to Propel Future of AI Drug Discovery
AMD will also make a USD 20 million investment in Absci, structured as a private investment in public equity (PIPE), underscoring the growing demand for innovative AI applications in drug discovery.
AI Drug Discovery | 10/01/2025 | By Aishwarya | 302
Syntekabio to Showcase its AI Drug Discovery Tech at Bio-IT World Expo
Syntekabio, a global artificial intelligence (AI) drug discovery pioneer, has announced its participation at the upcoming Bio-IT World Conference & Expo.
AI Drug Discovery | 12/04/2024 | By Aishwarya | 576
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy